·07/05/10 Silent Cerebral Ischemia Detected With Diffusion-Weighted Imaging in Patients Treated With Protected and Unprotected Carotid Artery Stenting
·07/05/10 Evaluation of the Paraoxonases as Candidate Genes for Stroke
·07/05/10 Incidence of Recurrent Subarachnoid Hemorrhage After Clipping for Ruptured Intracranial Aneurysms
·07/05/10 Revascularization End Points in Stroke Interventional Trials
·07/05/10 Vitamin Intervention for Stroke Prevention Trial
·07/05/10 Applying a Phase II Futility Study Design to Therapeutic Stroke Trials
·07/05/10 Intravenous Heparin Started Within the First 3 Hours After Onset of Symptoms as a Treatment for Acute Nonlacunar Hemispheric Cerebral Infarctions
·07/05/10 Outcome and Severe Hemorrhagic Complications of Intravenous Thrombolysis With Tissue Plasminogen Activator in Very Old (80 Years) Stroke Patients
·07/05/10 Emergent Stenting of Extracranial Internal Carotid Artery Occlusion in Acute Stroke Has a High Revascularization Rate
·07/05/10 Determinants of Staged Endovascular and Surgical Treatment Outcome of Brain Arteriovenous Malformations
·07/05/10 Clinical Course and Prediction of Mood, Behavior Problems, and Health Status of Their Young Children
·07/05/10 In-Hospital Medical Complications and Long-Term Mortality After Ischemic Stroke
·07/05/10 Heritability of the Function and Structure of the Arterial Wall
·07/05/10 NIHSS Training and Certification Using a New Digital Video Disk Is Reliable
·07/05/10 Variation in the Carotid Bifurcation Geometry of Young Versus Older Adults
·07/05/10 Nedd9 Protein, a Cas-L Homologue, Is Upregulated After Transient Global Ischemia in Rats
·07/05/10 Short-Term Administration of a New Free Radical Scavenger, Edaravone, Is More Effective Than its Long-Term Administration for the Treatment of Neonatal Hypoxic–Ischemic Encephalopathy
·07/05/10 Cerebral Blood Flow Thresholds for mRNA Synthesis After Focal Ischemia and the Effect of MK-801
·07/05/10 In Situ -Irradiation of a Brain Arteriovenous Malformation Model
·07/05/10 Cerebral Venous Malformations Have Distinct Genetic Origin From Cerebral Cavernous Malformations
·07/05/10 Electrocardiographic Left Atrial Abnormalities and Risk of Ischemic Stroke
·07/05/10 Apolipoprotein E Genotype and Incident Ischemic Stroke
·07/05/10 Perfusion MRI Abnormalities in Speech or Motor Transient Ischemic Attack Patients
·07/05/10 Heritability of Carotid Artery Distensibility in Hispanics
·07/05/10 Reversal of Dense Signs Predicts Recovery in Acute Ischemic Stroke
·07/05/10 Reliability and Validity of the Upper-Extremity Motor Activity Log-14 for Measuring Real-World Arm Use
·07/05/10 Poor Outcomes in Patients Who Do Not Receive Intravenous Tissue Plasminogen Activator Because of Mild or Improving Ischemic Stroke
·07/05/10 Economic Benefit of Increasing Utilization of Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke in the United States
·07/05/10 Two Treatments in One Subject Within 90 Hours Based on a Modified Magnetic Resonance Imaging Brain Clock Concept
·07/05/10 Looking Beyond the Lumen With MRI
·07/05/10 A Review of the Evidence for Problem Solving
·07/05/10 Time Trends of Ischemic Stroke Incidence and Mortality in Patients Diagnosed With First Atrial Fibrillation in 1980 to 2000
·07/05/10 Overnight Changes in the Cerebral Vascular Response to Isocapnic Hypoxia and Hypercapnia in Healthy Humans
·07/05/10 Significance of Susceptibility Vessel Sign on T2-Weighted Gradient Echo Imaging for Identification of Stroke Subtypes
·07/05/10 Absence of Microemboli on Transcranial Doppler Identifies Low-Risk Patients With Asymptomatic Carotid Stenosis

1 [2] [下一页] [尾页]